英文字典,中文字典,查询,解释,review.php


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       


安装中文字典英文字典辞典工具!

安装中文字典英文字典辞典工具!










  • Huntingtons Disease (HD) Chorea Treatment - AUSTEDO XR®
    The most common side effects of AUSTEDO XR are expected to be similar to AUSTEDO in people with Huntington’s disease or tardive dyskinesia These are not all the possible side effects of AUSTEDO XR or AUSTEDO Call your doctor for medical advice about side effects You are encouraged to report side effects of prescription drugs to the FDA
  • Austedo Austedo XR: Uses, Side Effects, Dosage Guide
    Austedo XR (extended-release tablet) is taken once daily, and Austedo tablets are taken twice daily What is Tardive dyskinesia (TD) and Huntington’s disease chorea Tardive dyskinesia (TD) is a nervous system disorder that causes repetitive, uncontrolled muscle movements, usually in the face (chewing, lip smacking, frowning, tongue movement
  • AUSTEDO XR AUSTEDO DOSAGE FORMS AND STRENGTHS
    • AUSTEDO XR and AUSTEDO are contraindicated in patients who are suicidal, and in patients with untreated or inadequately treated depression (4, 5 1) INDICATIONS AND USAGE AUSTEDO XR and AUSTEDO are vesicular monoamine transporter 2 (VMAT2) inhibitors indicated in adults for the treatment of: • Chorea associated with Huntington’s
  • Austedo: Huntingtons Disease Uses, Side Effects, Dosage
    Austedo is a prescription medication that is used to treat the involuntary movements (chorea) of Huntington's disease The most common side effects of Austedo in people with tardive dyskinesia include inflammation of the nose and throat (nasopharyngitis) and problems sleeping (insomnia) Austedo can increase the risk of depression and suicidal thoughts and behavior (suicidality) in patients
  • Approved Treatments for Huntingtons Disease
    Austedo and Austedo XR Available in tablets, the medications are taken orally once or twice daily, depending on the formulation Their active ingredient is similar to that of Xenazine, an older approved treatment for Huntington’s chorea, but it is designed to last longer in the body
  • AUSTEDO® XR: Tardive Dyskinesia and Huntingtons Chorea Treatment
    AUSTEDO® XR (deutetrabenazine) extended-release tablets is the first medication approved to treat both tardive dyskinesia and Huntington's disease chorea See safety info including Boxed Warning Teva Shared Solutions® 1-800-887-8100
  • Clinical Policy: Deutetrabenazine (Austedo, Austedo XR)
    Deutetrabenazine (Austedo ®, Austedo ® XR) is a vesicular monoamine transporter 2 (VMAT2) inhibitor FDA Approved Indication(s) Austedo and Austedo XR are indicated for the treatment of: • Chorea associated with Huntington’s disease • Tardive dyskinesia (TD) in adults Policy Criteria
  • Austedo XR Approved: A New Treatment Option for Tardive . . .
    The US Food and Drug Administration (FDA) has approved Teva Pharmaceuticals’ Austedo XR (deutetrabenazine) as a once-daily pill treatment option, available in 4 new tablet strengths (30, 36, 42, 48 mg), indicated in adults for tardive dyskinesia (TD) and Huntington disease (HD) chorea control 1


















中文字典-英文字典  2005-2009